We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine

NOX4 induces oxidative stress and apoptosis through upregulation of caspases 3 and 9 and downregulation of TIGAR in HCV-infected Huh-7 cells

    Muqddas Tariq

    Atta-ur-Rehman School of Applied Biosciences, National University of Sciences & Technology (NUST), Islamabad 44000, Pakistan

    ,
    Sobia Manzoor

    * Author for correspondence

    Atta-ur-Rehman School of Applied Biosciences, National University of Sciences & Technology (NUST), Islamabad 44000, Pakistan.

    ,
    Qazi Laeeque Ahmed

    Atta-ur-Rehman School of Applied Biosciences, National University of Sciences & Technology (NUST), Islamabad 44000, Pakistan

    ,
    Madiha Khalid

    Atta-ur-Rehman School of Applied Biosciences, National University of Sciences & Technology (NUST), Islamabad 44000, Pakistan

    &
    Waseem Ashraf

    Atta-ur-Rehman School of Applied Biosciences, National University of Sciences & Technology (NUST), Islamabad 44000, Pakistan

    Published Online:https://doi.org/10.2217/fvl.13.50

    Aim: The present study was designed to determine the potential role of oxidative stress in the induction of apoptosis in a transient in vitro model of HCV-infected Huh-7 cells. Material & methods: A transient in vitro infectivity model of a Huh-7 cell line was established using serum from HCV genotype 3a patients. Quantitative expression of selected genes was measured using real-time PCR. Results: A test of the apoptotic responses of cells under stressful conditions showed a significant increase in selected oxidative stress and apoptotic markers, along with a significant decrease in expression of antioxidants following inoculation in a time-dependent manner. A significant decrease in TIGAR and a significant increase in p53 expression levels at day 6 suggested the possible role of p53 and TIGAR in the induction of apoptosis and oxidative stimuli in experimental Huh-7/HCV cell lines. Conclusion: Collectively, the findings of the current study suggest a role for p53 and TIGAR in HCV-induced apoptosis in the presence of oxidative stress in a Huh-7 cell line.

    References

    • Lavanchy D. Evolving epidemiology of hepatitis C virus. Clin. Microbiol. Infect.17,107–115 (2011).
    • Lau JY, Xie X, Lai MM et al. Apoptosis and viral hepatitis. Semin. Liver Dis.18,169–176 (1998).
    • Bieche I, Asselah T, Laurendeau I et al. Molecular profiling of early stage liver fibrosis in patients with chronic hepatitis C virus infection. Virology332,130–144 (2005).
    • Fartoux L, Poujol-Robert A, Guechot J et al. Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C. Gut54,1003–1008 (2005).
    • Pekow JR, Bhan AK, Zheng H et al. Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis. Cancer109,2490–2496 (2007).
    • Piccoli C, Scrima R, Quarato G et al. Hepatitis C virus protein expression causes calcium-mediated mitochondrial bioenergetic dysfunction and nitro-oxidative stress. Hepatology46,58–65 (2007).
    • Choi J, Ou JH. Mechanisms of liver injury. III. Oxidative stress in the pathogenesis of hepatitis C virus. Am. J. Physiol. Gastrointest. Liver Physiol.290,847–851 (2006).
    • Bureau C, Bernad J, Chaouche N et al. Nonstructural 3 protein of hepatitis C virus triggers an oxidative burst in human monocytes via activation of NADPH oxidase. J. Biol. Chem.276,23077–23083 (2001).
    • Garcia-Mediavilla MV, Sanchez-Campos S, Gonzalez-Perez P et al. Differential contribution of hepatitis C virus NS5A and core proteins to the induction of oxidative and nitrosative stress in human hepatocyte-derived cells. J. Hepatol.43,606–613 (2005).
    • 10  Sheikh MY, Choi J, Qadri I et al. Hepatitis C virus infection: molecular pathways to metabolic syndrome. Hepatology47,2127–2133 (2008).
    • 11  Boudreau HE, Emerson SU, Korzeniowska A et al. Hepatitis C virus (HCV) proteins induce NADPH oxidase 4 expression in a transforming growth factor beta-dependent manner: a new contributor to HCV-induced oxidative stress. J. Virol.83,12934–12946 (2009).
    • 12  de Mochel NS, Seronello S, Wang SH et al. Hepatocyte NAD(P)H oxidases as an endogenous source of reactive oxygen species during hepatitis C virus infection. Hepatology.52,47–59 (2010).
    • 13  De Minicis S, Brenner DA. NOX in liver fibrosis. Arch. Biochem. Biophys.462,266–272 (2007).
    • 14  Seronello S, Sheikh MY, Choi J. Redox regulation of hepatitis C in nonalcoholic and alcoholic liver. Free Radic. Biol. Med.43,869–882 (2007).
    • 15  Herrera B, Alvarez AM, Sanchez A et al. Reactive oxygen species (ROS) mediates the mitochondrial-dependent apoptosis induced by transforming growth factor (beta) in fetal hepatocytes. FASEB J.15,741–751 (2001).
    • 16  Herrera B, Fernandez M, Alvarez AM et al. Activation of caspases occurs downstream from radical oxygen species production, Bcl-xL down-regulation, and early cytochrome C release in apoptosis induced by transforming growth factor beta in rat fetal hepatocytes. Hepatology34,548–556 (2001).
    • 17  Franklin CC, Rosenfeld-Franklin ME, White C et al. TGFbeta1-induced suppression of glutathione antioxidant defenses in hepatocytes: caspase-dependent post-translational and caspase-independent transcriptional regulatory mechanisms. FASEB J.17,1535–1537 (2003).
    • 18  Herrera B, Murillo MM, Alvarez-Barrientos A et al. Source of early reactive oxygen species in the apoptosis induced by transforming growth factor-beta in fetal rat hepatocytes. Free Radic. Biol. Med.36,16–26 (2004).
    • 19  Diez-Fernandez C, Andres D, Cascales M. Attenuating effects of heat shock against TGF-beta1-induced apoptosis in cultured rat hepatocytes. Free Radic. Biol. Med.33,835–846 (2002).
    • 20  Shin JY, Hur W, Wang JS et al. HCV core protein promotes liver fibrogenesis via up-regulation of CTGF with TGF-beta1. Exp. Mol. Med.37,138–145 (2005).
    • 21  Taniguchi H, Kato N, Otsuka M et al. Hepatitis C virus core protein upregulates transforming growth factor-beta 1 transcription. J. Med. Virol.72,52–59 (2004).
    • 22  Lambeth JD, Kawahara T, Diebold B. Regulation of NOX and Duox enzymatic activity and expression. Free Radic. Biol. Med.43,319–331 (2007).
    • 23  Lehmann E, El-Tantawy WH, Ocker M et al. The heme oxygenase 1 product biliverdin interferes with hepatitis C virus replication by increasing antiviral interferon response. Hepatology51,398–404 (2010).
    • 24  Chung SW, Hall SR, Perrella MA. Role of haem oxygenase-1 in microbial host defence. Cell. Microbiol.11,199–207 (2009).
    • 25  Choi BM, Pae HO, Jeong YR et al. Critical role of heme oxygenase-1 in Foxp3-mediated immune suppression. Biochem. Biophys. Res. Commun.327,1066–1071 (2005).
    • 26  Pae HO, Oh GS, Choi BM et al. Carbon moNOXide produced by heme oxygenase-1 suppresses T cell proliferation via inhibition of IL-2 production. J. Immunol.172,4744–4751 (2004).
    • 27  Li J, Yuan J. Caspases in apoptosis and beyond. Oncogene27,6194–6206 (2008).
    • 28  Pop C, Salvesen GS. Human caspases: activation, specificity, and regulation. J. Biol. Chem.284,21777–21781 (2009).
    • 29  Sasaki Y. Does oxidative stress participate in the development of hepatocellular carcinoma? J. Gastroenterol.41,1135–1148 (2006).
    • 30  Ott M, Gogvadze V, Orrenius S et al. Mitochondria, oxidative stress and cell death. Apoptosis12,913–922 (2007).
    • 31  Li PF, Dietz R, von Harsdorf R. p53 regulates mitochondrial membrane potential through reactive oxygen species and induces cytochrome C-independent apoptosis blocked by Bcl-2. EMBO J.18,6027–6036 (1999).
    • 32  Lotem J, Peled-Kamar M, Groner Y et al. Cellular oxidative stress and the control of apoptosis by wild-type p53, cytotoxic compounds, and cytokines. Proc. Natl Acad. Sci. USA93,9166–9171 (1996).
    • 33  Zhang XD, Qin ZH, Wang J. The role of p53 in cell metabolism. Acta Pharmacol. Sin.31,1208–1212 (2010).
    • 34  Jen KY, Cheung VG. Identification of novel p53 target genes in ionizing radiation response. Cancer Res.65,7666–7673 (2005).
    • 35  Bensaad K, Tsuruta A, Selak MA et al. TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell126,107–120 (2006).
    • 36  Cook JA, Gius D, Wink DA et al. Oxidative stress, redox, and the tumor microenvironment. Semin. Radiat. Oncol.14,259–266 (2004).
    • 37  Jahan S, Samreen B, Khaliq S et al. HCV entry receptors as potential targets for siRNA-based inhibition of HCV. Genet. Vaccines Ther.9,15 (2011).
    • 38  Gong G, Waris G, Tanveer R, Siddiqui A. Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-kappa B. Proc. Natl Acad. Sci. USA98,9599–9604 (2001).
    • 39  Okuda M, Li K, Beard MR et al. Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology122,366–375 (2002).
    • 40  Ushio-Fukai M. Compartmentalization of redox signaling through NADPH oxidase-derived ROS. Antioxid. Redox. Signal.11,1289–1299 (2009).
    • 41  Sanchez A, Alvarez AM, Benito M et al. Apoptosis induced by transforming growth factor-beta in fetal hepatocyte primary cultures: involvement of reactive oxygen intermediates. J. Biol. Chem.271,7416–7422 (1996).
    • 42  Chiang E, Dang O, Anderson K et al. Cutting edge: apoptosis-regulating signal kinase 1 is required for reactive oxygen species-mediated activation of IFN regulatory factor 3 by lipopolysaccharide. J. Immunol.176,5720–5724 (2006).
    • 43  Cucoranu I, Clempus R, Dikalova A et al. NAD(P)H oxidase 4 mediates transforming growth factor-beta1-induced differentiation of cardiac fibroblasts into myofibroblasts. Circ. Res.97,900–907 (2005).
    • 44  Ikeda R, Ishii K, Hoshikawa Y et al. Reactive oxygen species and NADPH oxidase 4 induced by transforming growth factor beta1 are the therapeutic targets of polyenylphosphatidylcholine in the suppression of human hepatic stellate cell activation. Inflamm. Res.60,597–604 (2011).
    • 45  Guo X, Shin VY, Cho CH. Modulation of heme oxygenase in tissue injury and its implication in protection against gastrointestinal diseases. Life Sci.69,3113–3119 (2001).
    • 46  Choi BM, Pae HO, Kim YM et al. Nitric oxide-mediated cytoprotection of hepatocytes from glucose deprivation-induced cytotoxicity: involvement of heme oxygenase-1. Hepatology37,810–823 (2003).
    • 47  Abdalla MY, Ahmad IM, Spitz DR et al. Hepatitis C virus-core and non structural proteins lead to different effects on cellular antioxidant defenses. J. Med. Virol.76,489–497 (2005).
    • 48  Abdalla MY, Britigan BE, Wen F et al. Down-regulation of heme oxygenase-1 by hepatitis C virus infection in vivo and by the in vitro expression of hepatitis C core protein. J. Infect. Dis.190,1109–1118 (2004).
    • 49  Black D, Bird MA, Samson CM et al. Primary cirrhotic hepatocytes resist TGFbeta-induced apoptosis through a ROS-dependent mechanism. J. Hepatol.40,942–951 (2004).
    • 50  Carmona-Cuenca I, Roncero C, Sancho P et al. Upregulation of the NADPH oxidase NOX4 by TGF-beta in hepatocytes is required for its pro-apoptotic activity. J. Hepatol.49,965–976 (2008).
    • 51  Sancho P, Bertran E, Caja L et al. The inhibition of the epidermal growth factor (EGF) pathway enhances TGF-beta-induced apoptosis in rat hepatoma cells through inducing oxidative stress coincident with a change in the expression pattern of the NADPH oxidases (NOX) isoforms. Biochim. Biophys. Acta1793,253–263 (2008).
    • 52  Lan L, Gorke S, Rau SJ et al. Hepatitis C virus infection sensitizes human hepatocytes to TRAIL-induced apoptosis in a caspase 9-dependent manner. J. Immunol.181,4926–4935 (2008).
    • 53  Matoba S, Kang JG, Patino WD et al. p53 regulates mitochondrial respiration. Science312,1650–1653 (2006).
    • 54  Murray-Zmijewski F, Slee EA, Lu X. A complex barcode underlies the heterogeneous response of p53 to stress. Nat. Rev. Mol. Cell Biol.9,702–712 (2008).
    • 55  Macip S, Igarashi M, Berggren P et al. Influence of induced reactive oxygen species in p53-mediated cell fate decisions. Mol. Cell. Biol.23,8576–8585 (2003).
    • 56  Bensaad K, Cheung EC, Vousden KH. Modulation of intracellular ROS levels by TIGAR controls autophagy. EMBO J.28,3015–3026 (2009).
    • 57  Sengupta S, Harris CC. p53: traffic cop at the crossroads of DNA repair and recombination. Nat. Rev. Mol. Cell Biol.6,44–55 (2005).
    • 58  Bantel H, Lugering A, Poremba C et al. Caspase activation correlates with the degree of inflammatory liver injury in chronic hepatitis C virus infection. Hepatology34,758–767 (2001).
    • 59  Calabrese F, Pontisso P, Pettenazzo E et al. Liver cell apoptosis in chronic hepatitis C correlates with histological but not biochemical activity or serum HCV-RNA levels. Hepatology31,1153–1159 (2001).
    • 60  Fischer R, Baumert T, Blum HE. Hepatitis C virus infection and apoptosis. World J. Gastroenterol.13,4865–4872 (2007).
    • 61  Hiscott J, Kwon H, Genin P. Hostile takeovers: viral appropriation of the NF-kappaB pathway. J. Clin. Invest.107,143–151 (2001).
    • 62  Hussain SP, Hofseth LJ, Harris CC. Radical causes of cancer. Nat. Rev. Cancer3,276–285 (2003).
    • 63  Ryan KM, Ernst MK, Rice NR et al. Role of NF-kappaB in p53-mediated programmed cell death. Nature404,892–897 (2000).
    • 101  Primer3 (v. 0.4.0). Pick primers from a DNA sequence. http://frodo.wi.mit.edu
    • 102  NCBI. Gene. www.ncbi.nlm.nih.gov/gene
    • 103  NCBI/Primer-BLAST: finding primers specific to your PCR template (using Primer3 and BLAST). www.ncbi.nlm.nih.gov/tools/primer-blast